RecruitMe Clinical Trial
Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia - First Episode Study
Brain Imaging Study and Brief Treatment - People with Hallucinations and Delusions
| Sponsor: | NIMH |
| Enrolling: | Male and Female Patients |
| Study Length: | 1 Months |
| Clinic Visits: | 6 |
| Age Range: | Between 18 and 35 years old |
| IRB Number: | 7474 |
| Contact: | Brooke Lundgren: 646-774-5579 / Brooke.Lundgren@nyspi.columbia.edu |
Additional Study Information:
Are you between the ages of 18-35? Do you have schizophrenia or schizoaffective disorder? Researchers at the New York State Psychiatric Institute are currently seeking participants who are interested in a brief trial of anti-psychotic medication. This study will include: - magnetic resonance imaging (MRI) - a physical exam - clinical and neurocognitive assessments over a four-week period. If all elements of the study are completed, participants can make up to $550.00. For further information about the study and your eligibility, please contact us.
